{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:15:32Z","timestamp":1792030532539,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111215","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:59:15Z","timestamp":1733731155000},"page":"111215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The neuropharmacology of kratom, a novel psychoactive natural product"],"prefix":"10.1016","volume":"136","author":[{"given":"MeShell","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Prozialeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2024.111215_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/15563650701241795","article-title":"Opioid receptors and legal highs: Salvia divinorum and Kratom","volume":"46","author":"Babu","year":"2008","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0010","first-page":"C681","article-title":"Evaluation of G protein bias and \u03b2-arrestin 2 signaling in opioid-induced respiratory depression","volume":"321","author":"Bateman","year":"2021","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0015","first-page":"1","article-title":"A review on Mitragyna speciosa (Rubiaceae) as a prominent medicinal plant based on ethnobotany, phytochemistry and pharmacological activities","author":"Begum","year":"2024","journal-title":"Nat. Prod. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111215_bb0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jep.2017.03.020","article-title":"A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: implications for products sold as kratom","volume":"202","author":"Brown","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.696461","article-title":"The antidepressant-like and analgesic effects of Kratom alkaloids are accompanied by changes in low frequency oscillations but not \u0394FosB accumulation","volume":"12","author":"Buckhalter","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.pnpbp.2024.111215_bib386","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1021\/acschemneuro.1c00149","article-title":"Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom","volume":"12","author":"Chakraborty","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"22","key":"10.1016\/j.pnpbp.2024.111215_bib387","doi-asserted-by":"crossref","first-page":"16553","DOI":"10.1021\/acs.jmedchem.1c01111","article-title":"Oxidative Metabolism as a Modulator of Kratom\u2019s Biological Actions","volume":"64","author":"Chakraborty","year":"2021","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111215_bb0040","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/molecules27072208","article-title":"LC\/ESI\/TOF-MS characterization, anxiolytic and antidepressant-like effects of Mitragyna speciosa Korth extract in diabetic rats","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2019.05.005","article-title":"Kratom as a substitute for opioids: results from an online survey","volume":"202","author":"Coe","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/10550887.2020.1788914","article-title":"Prevalence and characteristics of self-reported kratom use in a representative US general population sample","volume":"38","author":"Covvey","year":"2020","journal-title":"J. Addict. Dis."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111215_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pop.2016.02.004","article-title":"Depression screening, diagnosis, and treatment across the lifespan","volume":"43","author":"Cozine","year":"2016","journal-title":"Prim. Care"},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2024.111215_bb0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: a comprehensive review","volume":"9","author":"Eastlack","year":"2020","journal-title":"Pain Ther."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0070","series-title":"Kratom and Other Mitragynines: The Chemistry and Pharmacology of Opioids from a Non-Opium","first-page":"57","article-title":"Chapter 5. The botany of Mitragyna speciosa (Korth.) Havil. and related species","author":"Eisenman","year":"2014"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111215_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229646","article-title":"Evaluating kratom alkaloids using PHASE","volume":"15","author":"Ellis","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107946","article-title":"Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through \u03b1-adrenoceptor mechanism","volume":"209","author":"Foss","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2012.06.029","article-title":"Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model","volume":"1470","author":"Garc\u00eda","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107849","article-title":"Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic","volume":"208","author":"Garcia-Romeu","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of Kratom use and health impact in the US\u2014results from an online survey","volume":"176","author":"Grundmann","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0100","first-page":"1","article-title":"Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation","author":"Grundmann","year":"2022","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.764885","article-title":"Evaluation of kratom opioid derivatives as potential treatment option for alcohol use disorder","volume":"12","author":"Gutridge","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751656","article-title":"Kratom alkaloids: interactions with enzymes, receptors, and cellular barriers","volume":"12","author":"Hanapi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111215_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/0269881119844186","article-title":"Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats","volume":"33","author":"Hassan","year":"2019","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111215_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12576-014-0304-0","article-title":"Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats","volume":"64","author":"Hazim","year":"2014","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0125","doi-asserted-by":"crossref","first-page":"1403140","DOI":"10.3389\/fphar.2024.1403140","article-title":"Kratom safety and toxicology in the public health context: research needs to better inform regulation","volume":"15","author":"Henningfield","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172557","article-title":"Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test","volume":"859","author":"Holanda","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.pnpbp.2024.111215_bb0135","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1073\/pnas.121635798","article-title":"Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor","volume":"98","author":"Hwang","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111215_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.phymed.2010.08.011","article-title":"Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression","volume":"18","author":"Idayu","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.708055","article-title":"Mitragynine (Kratom)-induced cognitive impairments in mice resemble \u03949-THC and morphine effects: reversal by cannabinoid CB1 receptor antagonism","volume":"12","author":"Iman","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111215_bb0150","article-title":"The potential for Kratom as an antidepressant and antipsychotic","volume":"93","author":"Johnson","year":"2020","journal-title":"Yale J. Biol. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111215_bb0155","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.0c00075","article-title":"Metabolism of a Kratom alkaloid metabolite in human plasma increases its opioid potency and efficacy","volume":"3","author":"Kamble","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0160","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","author":"Kruegel","year":"2017","journal-title":"Neuropharmacology."},{"issue":"21","key":"10.1016\/j.pnpbp.2024.111215_bb0165","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the Mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111215_bb0170","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of Mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111215_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2007.01.061","article-title":"Fos-like immunoreactivity in rat dorsal raphe nuclei induced by alkaloid extract of Mitragyna Speciosa","volume":"416","author":"Kumarnsit","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0180","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/acs.jnatprod.3c00092","article-title":"Metabolite and molecular characterization of Mitragyna speciosa identifies developmental and genotypic effects on monoterpene indole and Oxindole alkaloid composition","volume":"86","author":"Laforest","year":"2023","journal-title":"J. Nat. Prod."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111215_bb0185","article-title":"Phytochemical characterization of the leaves of Mitragyna speciosa grown in U.S.A","volume":"4","author":"Le\u00f3n","year":"2009","journal-title":"Nat. Prod. Commun."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.111215_bb0190","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1021\/acs.jmedchem.1c00726","article-title":"Activity of Mitragyna speciosa (\u201cKratom\u201d) alkaloids at serotonin receptors","volume":"64","author":"Le\u00f3n","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0195","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.jemermed.2022.02.004","article-title":"Acute renal insufficiency associated with consumption of hydrocodone-and morphine-adulterated kratom (Mitragyna speciosa)","volume":"63","author":"LeSaint","year":"2022","journal-title":"J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0205","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518779829","article-title":"Physiological and functional basis of dopamine receptors and their role in neurogenesis: possible implication for Parkinson\u2019s disease","volume":"12","author":"Mishra","year":"2018","journal-title":"J. Exp. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111215_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction","volume":"10","author":"Nestler","year":"2001","journal-title":"Am. J. Addict."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111215_bb0215","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4315\/JFP-21-319","article-title":"Multistate outbreak investigation of salmonella infections linked to Kratom: a focus on traceback, laboratory, and regulatory activities","volume":"85","author":"Nsubuga","year":"2022","journal-title":"J. Food Prot."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based Kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2021.02.004","article-title":"Past-year Kratom use in the U.S.: estimates from a nationally representative sample","author":"Palamar","year":"2021","journal-title":"Am. J. Prev. Med."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111215_bb0230","article-title":"Pharmacology and toxicology of kratom","volume":"124","author":"Pohanka","year":"2023","journal-title":"Brat. Med. J.\/Bratisl. Lek. Listy"},{"issue":"06","key":"10.1016\/j.pnpbp.2024.111215_bb0235","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2006-959578","article-title":"A new indole alkaloid, 7 \u03b1-hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand","volume":"60","author":"Ponglux","year":"1994","journal-title":"Planta Med."},{"issue":"15","key":"10.1016\/j.pnpbp.2024.111215_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17155512","article-title":"Evaluation of the Mitragynine content, levels of toxic metals and the presence of microbes in Kratom products purchased in the Western suburbs of Chicago","volume":"17","author":"Prozialeck","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0245","series-title":"Effects of alkaloid extract from Kratom (Mitragyna speciosa (Korth.) Havil) leaves on antipsychotics-driven parkinsonism. 1st International Symposium on","author":"Reakkamnuan","year":"2022"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111329","article-title":"Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: insights from dosing amount versus frequency","volume":"260","author":"Rogers","year":"2024","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0255","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health","author":"SAMHSA","year":"2022"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/plants12040949","article-title":"Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand","volume":"12","author":"Sengnon","year":"2023","journal-title":"Plants"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0265","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/2405461503666180420120649","article-title":"Substance use disorder related to kratom (Mitragyna speciosa) use in Malaysia","volume":"8","author":"Singh","year":"2019","journal-title":"Curr. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111215_bb0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02791072.2018.1555345","article-title":"Long-term cognitive effects of Kratom (Mitragyna speciosa Korth.) use","volume":"51","author":"Singh","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0275","article-title":"Patterns and reasons for Kratom (Mitragyna speciosa) use among current and former opioid poly-drug users","author":"Singh","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111215_bb0280","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/ADM.0000000000000876","article-title":"The use of Kratom (Mitragyna speciosa Korth.) among people who co-use heroin and methamphetamine in Malaysia","volume":"16","author":"Singh","year":"2022","journal-title":"J. Addict. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111215_bb0285","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1037\/pha0000518","article-title":"Social, psychological, and substance use characteristics of US adults who use kratom: initial findings from an online, crowdsourced study","volume":"30","author":"Smith","year":"2022","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0290","article-title":"Discovery of procyanidin condensed tannins of (\u2212)-epicatechin from Kratom, Mitragyna speciosa, as virucidal agents against SARS-CoV-2","volume":"133059","author":"Sureram","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111215_bb0295","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1248\/cpb.52.916","article-title":"Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa","volume":"52","author":"Takayama","year":"2004","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111215_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030620","article-title":"Clinical pharmacokinetic assessment of Kratom (Mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants","volume":"14","author":"Tanna","year":"2022","journal-title":"Pharmaceutics"},{"issue":"16","key":"10.1016\/j.pnpbp.2024.111215_bb0305","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0024-3205(98)00075-7","article-title":"Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice","volume":"62","author":"Thongpradichote","year":"1998","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111215_bb0310","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00213-018-4872-1","article-title":"The 5-HT1B receptor-a potential target for antidepressant treatment","volume":"235","author":"Tiger","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103817","article-title":"Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom","volume":"108","author":"Tobacyk","year":"2022","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0320","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1248\/bpb.20.338","article-title":"Effects of mitragynine on cAMP formation mediated by \u03b4-opiate receptors in NG108-15 cells","volume":"20","author":"Tohda","year":"1997","journal-title":"Biol. Pharm. Bull."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.111215_bb0325","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/Corynantheidine pseudoindoxyls as opioid analgesics with mu Agonism and delta antagonism, which do not recruit beta-arrestin-2","volume":"59","author":"Varadi","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111215_bb0330","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/SAR.S164261","article-title":"Current perspectives on the impact of Kratom use","volume":"10","author":"Veltri","year":"2019","journal-title":"Subst. Abus. Rehabil."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0340","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2009.12.003","article-title":"The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy","volume":"21","author":"Vicknasingam","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0345","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11011-019-00477-2","article-title":"Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism","volume":"34","author":"Vijeepallam","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108310","article-title":"Lyophilized Kratom tea as a therapeutic option for opioid dependence","volume":"216","author":"Wilson","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0355","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-020-01034-7","article-title":"Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal","author":"Wilson","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0360","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","article-title":"Recent developments in biased agonism","volume":"27","author":"Wisler","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111215_bb0365","first-page":"35636","article-title":"Prevalence of kratom use and co-occurring substance use disorders in the United States","volume":"23","author":"Xu","year":"2021","journal-title":"Primary Care Comp. CNS Dis."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0370","article-title":"The forced swim test as a model of depressive-like behavior","volume":"97","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0375","first-page":"1","article-title":"Mitragynine improves cognitive performance in morphine-withdrawn rats","author":"You","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111215_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.11.002","article-title":"The effect of mitragynine on extracellular activity of brain dopamine and its metabolites","volume":"178","author":"Yusoff","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2024.111215_bb0385","series-title":"Flavonoids: Antioxidant Powerhouses and their Role in Nanomedicine","author":"Zahra","year":"2024"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:28:23Z","timestamp":1745854103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":79,"alternative-id":["S0278584624002835"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111215","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuropharmacology of kratom, a novel psychoactive natural product","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111215"}}